Objective Capital Advises Healthcare IT Company on Its Sale to Kinderhook Industries

Posted May 01, 2018 by OCP | Post a Comment

Los Angeles, CA April 24, 2018 — Objective Capital Partners, a leading middle market investment banking firm, is pleased to announce that it served as the exclusive financial advisor to StudyKIK LLC, a rapidly-growing healthcare IT company, on its acquisition by Kinderhook Industries LLC.

“Matt and his team have done a remarkable job in creating a leading patient recruiting platform which is having an enormous impact by making it dramatically more efficient for clinical trial companies to find and engage the high-fit trial volunteers they need to bring new and innovative treatments to market,” said Channing Hamlet, Managing Director of Objective Capital Partners. “We are privileged to have had this opportunity to help StudyKIK and couldn’t be more excited about the future of the company.”


Healthcare & Life Sciences, Healthcare, Life Sciences

SoCal Capital Summit on M&A Healthcare Trends & Opportunities

Posted November 04, 2017 by David Crean | Post a Comment


Objective Capital’s David H. Crean to be Guest Panelist at ACG Orange County's CEO Signature Event on November 15, 2017

San Diego, November 6, 2017 — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, will be a guest panelist speaker at ACG Orange County’s CEO Signature Event entitled SoCal Capital Summit on November 15, 2017.   Dr. Crean and the fellow panelists will address M&A Healthcare Trends and Opportunities.  He will be joined by Greg Cunniff, CFO, NVISION Eye Centers, and Steven Shill, Partner and National Healthcare Practice Leader at BDO.


Healthcare & Life Sciences, David H. Crean, Life Sciences, M&A Trends, SoCal Capital Summit, ACG Orange County, Uncategorized

Objective Capital’s Dr. David Crean to Address International Bar Association’s 5th Annual World Life Sciences Conference in San Diego, CA

Posted May 30, 2017 by David Crean | Post a Comment

Panel Discussion on Life Sciences Transactions, Research Collaborations, and Licensing Models to be presented on June 17, 2017

San Diego, CA- May 31, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will serve as a panel member and address legal professionals at the 5th Annual World Life Sciences Conference, June 16–17, 2017 at the Westin San Diego Gaslamp Quarter, San Diego, CA. The conference is presented by the International Bar Association (IBA), a global voice for the legal profession. The event will feature dynamic roundtable sessions covering the hottest topics and the latest developments from across the different sectors of the Life Science Industry.


Healthcare & Life Sciences, International Bar Association, Licensing, Collaborations, David H. Crean, IBA, Life Sciences, objective capital partners, Partnerships, Investment banking, Uncategorized

Objective Capital Partners Strengthens Its Healthcare & Life Sciences Investment Banking Practice with the Addition of Jack J. Florio

Posted January 18, 2017 by admin | Post a Comment

San Diego, CA- January 18, 2017 - Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to welcome the addition of Jack J. Florio fueling its ability to secure and execute high quality deals in the healthcare & life sciences space.  Mr. Florio brings more 40 years’ of global life sciences experience in major pharmaceutical, biotechnology, medical devices and digital health companies.  He has held senior management roles in both small and large companies including CEO, Corporate Development and Business Development.  He will serve as Managing Director and help with execution of the firm’s investment banking activities in the healthcare & life science space alongside David H. Crean, Ph.D..


Healthcare & Life Sciences, Jack Florio, objective capital partners, Investment banking, Uncategorized

This article is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.

Our Services

Learn about our services and how we can help you sell your business successfully.


Contact Us

San Diego Office:
3636 Nobel Dr., Suite 160
San Diego, CA 92122

Los Angeles Office:
10100 Santa Monica Blvd., Suite 300
Los Angeles, CA 90067

Trever Acers
Managing Director
858.663.8662 telephone

Channing Hamlet
Managing Director
858.342.4939 telephone

David H. Crean, Ph.D.
Managing Director
858.461.9490 telephone

Jack J. Florio
Managing Director
858.864.4339 telephone